Trial intelligence / Profile preview

Ciclosporin with/without Hydrocortisone for Dry Eye in Sjögren's Syndrome

NCT04597762Completed

Sponsor
Klinik Hietzing
Start
Aug 2020
Primary completion
Mar 2021
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised trial of cyclosporine in keratoconjunctivitis sicca (KCS) (2 arms), sponsored by Klinik Hietzing. Primary endpoints: Tear Film Breakup Time at 6 months, Corneal Fluorescein Staining at 6 months and 1 more. Started Aug 2020; status: completed.

02

Drugs

cyclosporine
03

Conditions

keratoconjunctivitis sicca (KCS)

Beyond the preview

Go deeper on NCT04597762.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04597762.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call